Giving a P2Y12 inhibitor anti-clotting drug to patients with coronary artery disease is associated with lower rates of ...

A major international study has found that heart patients, particularly seniors, may benefit more from newer blood-thinning ...

The coronary stents market has become a vital segment within the broader cardiovascular healthcare industry. With the rising prevalence of coronary artery diseases and growing awareness of ...

In patients undergoing chronic total occlusion (CTO) percutaneous coronary intervention (PCI), stenting demonstrated improved ...

Giving a P2Y12 inhibitor anti-clotting drug to patients with coronary artery disease is associated with lower rates of ...

This week, a number of companies, big and small, shared updates on their cardiovascular technology innovations at EuroPCR 2025 in Paris.